Skip to main content

Advertisement

SpringerLink
Log in

Hepatic neoplasia: reflections and ruminations

  • Review Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abe K, Kurata T, Shikata T, Tennant BC (1988) Enzyme-altered liver cell foci in woodchucks infected with woodchuck hepatitis virus. Jpn J Cancer Res 79:466–472

    Google Scholar 

  2. Ackerknecht EH (1958) Historical notes on cancer. Med Hist 2:114–119

    Google Scholar 

  3. Alison MR, Sarraf CE (1994) Liver cell death: patterns and mechanisms. Gut 35:577–581

    Google Scholar 

  4. Altmann H-W (1977) Eisenhaltige Kerneinschlüsse bei menschlicher Pigmentcirrhose. Virchows Arch [B] 23:277–290

    Google Scholar 

  5. Altmann H-W (1977) Consideraciones sobre el significado y la nomenclatura de los tumores hepaticos en el hombre. Patologia N.e extraordinario II. 10:1–16

    Google Scholar 

  6. Altmann H-W (1978) Pathology of liver tumors. In: Remmer H, Bolt HM, Bannasch P, Popper H (eds) Primary liver tumors. Falk symposium 25. MTP Press, Lancaster, pp 53–71

    Google Scholar 

  7. Altmann H-W (1983) Neubildungen der Leber: Pathologie und Pathogenese. In: Häring R (ed) Chirurgie der Leber. Edition Medizin, Weinheim, pp 167–187

    Google Scholar 

  8. Altmann H-W (1984) Neubildungen der Leber. Verh Dtsch Krebsges 5:423–435

    Google Scholar 

  9. Altmann H-W (1987) Morphologische Aspekte der hepatischen Neubildungen des Menschen. In: Tittor W, Schwalbach G (eds) Lebertumoren, Ursache, Verlauf und Therapie. Demeter, Gräfeling, pp 87–106

    Google Scholar 

  10. Altmann H-W (1994) Hepatic newformations. Pathol Res Pract 190:513–577

    Google Scholar 

  11. Ames BN, Gold S (1991) Endogenous mutagens and the causes of aging and cancer. Mutat Res 250:3–16

    Google Scholar 

  12. Ames BN, Gold S (1991) Carcinogenesis mechanisms: The debate continues. Science 252:902

    Google Scholar 

  13. Anderson MW, Reynolds SH, You M, Maronpot RM (1992) Role of proto-oncogene activation in carcinogenesis. Environ Health Perspect 98:13–24

    Google Scholar 

  14. Anundi I, Kauffman FC, te Koppele JM, Popp JA, Thurman R (1989) Adenine nucleotides and carbohydrates in subpopulations of hepatic nodules with normal and compromised microcirculation. Cancer Res 49:3282–3286

    Google Scholar 

  15. Ashby J (1992) Prediction of non-genotoxic carcinogenesis. Toxicol Lett 64/65:605–612

    Google Scholar 

  16. Ashby J, Paton D (1993) The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures. Mutat Res 286:3–74

    Google Scholar 

  17. Aterman K (1987) Localized hepatocarcinogenesis: The response of the liver and of the kidney to implanted carcinogens. J Cancer Res Clin Oncol 113:507–538

    Google Scholar 

  18. Aterman K (1992) The stem cells of the liver — a selective review. J Cancer Res Clin Oncol 118:87–115

    Google Scholar 

  19. Bacon BR, Britton RS (1990) The pathology of hepatic iron overload: A free radical-mediated process? Hepatology 11:127–137

    Google Scholar 

  20. Balázs M, Csermely A (1986) Primary tumors of the liver. A review of 249 cases. Acta Morphol Hung 34:267–288

    Google Scholar 

  21. Bannasch P (1968) The cytoplasm of hepatocytes during carcinogenesis. Electron and light microscopical investigations of the nitrosomorpholine-intoxicated rat liver. Recent Results Cancer Res 19:1–100

    Google Scholar 

  22. Bannasch P (1974) Carcinogen-induced cellular thesaurismoses and neoplastic cell transformation. Recent Results Cancer Res 44:115–126

    Google Scholar 

  23. Bannasch P (1975) Chemical carcinogenesis: Early morphological and cytochemical changes. In: The prediction of chronic toxicity from short term studies. (Proceedings of the European Society of Toxicology, vol 17) Excerpta Medica International Congress series, number 376. Excerpta Medica, Amsterdam, pp 21–31

    Google Scholar 

  24. Bannasch P (1975) Die Cytologie der Hepatocarcinogenese. In: Altmann H-W et al. (eds) Handbuch der allgemeinen Pathologie, volume VI/7, Geschwülste, Tumors III. Springer, Berlin Heidelberg New York, pp 124–276

    Google Scholar 

  25. Bannasch P (1979) Morphologie und Pathogenese der Lebertumoren. In: Kühn HA, Wernze H (eds) Klinische Hepatologie. Georg Thieme Verlag, Stuttgart, pp 6.386–6.403

    Google Scholar 

  26. Bannasch P (1986) Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis 7:689–695

    Google Scholar 

  27. Bannasch P (1988) Phenotypic cellular changes as indicators of stages during neoplastic development. In: Iversen OH (ed) Theories of carcinogenesis. Hemisphere Publishing, Washington, pp 231–249

    Google Scholar 

  28. Bannasch P (1990) Pathobiology of chemical hepatocarcinogenesis: Recent progress and perspectives. Part I: Cytomorphological changes and cell proliferation. J Gastroenterol Hepatol 5:149–159

    Google Scholar 

  29. Bannasch P (1990) Pathobiology of chemical hepatocarcinogenesis: Recent progress and perspectives. Part II: Metabolic and molecular changes. J Gastroenterol Hepatol 5:310–320

    Google Scholar 

  30. Bannasch P (1991) The multistage evolution of invasive neoplasia. Triangle 30:101–111

    Google Scholar 

  31. Bannasch P, Klinge O (1971) Hepatozelluläre Glykogenose und Hepatombildung beim Menschen. Virchows Arch [A] 352:157–164

    Google Scholar 

  32. Bannasch P, Müller H-A (1964) Lichtmikroskopische Untersuchungen über die Wirkung von N-Nitrosomorpholin auf die Leber von Ratte und Maus. Arzneimittelforschung 14:805–814

    Google Scholar 

  33. Bannasch P, Zerban H (1990) Tumours of the liver. In: Turusov VS, Mohr U (eds) Pathology of tumours in laboratory animals, Vol. I. Tumours of the rat. 2nd edn. International Agency of Research on Cancer, Lyon, pp 199–240

    Google Scholar 

  34. Bannasch P, Zerban H (1992) Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response. In: Vainio H, Magee PN, McGregor DB, McMichael AJ (eds) Mechanisms of carcinogenesis in risk identification. International Agency for Research on Cancer, Lyon, pp 389–427

    Google Scholar 

  35. Bannasch P, Moore MA, Klimek F, Zerban H (1982) Biological markers of preneoplastic foci and neoplastic nodules in rodent liver. Toxicol Pathol 10:19–36

    Google Scholar 

  36. Bannasch P, Enzmann H, Klimek F, Weber E, Zerban H (1989) Significance of sequential changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis. Toxicol Pathol 17:617–628

    Google Scholar 

  37. Bannasch P, Enzmann H, Hacker HJ, Weber E, Zerban H (1989) Comparative pathobiology of heaptic pre-neoplasia. In: Bannasch P, Keppler D, Weber G (eds) Liver Carcinoma. Falk Symposium 51. Kluwer Academic Publishers, Dordrecht, pp 55–76

    Google Scholar 

  38. Bannasch P, Hacker HJ, Klimek F, Mayer D, Stumpf H, Zerban H (1991) Cytochemical microbiochemical and molecular genetic analysis of chemical carcinogenesis. Prog Histochem Cytochem 23:45–60

    Google Scholar 

  39. Bannasch P, Jahn UR, Zerban H (1992) Preneoplastic lesions as early indicators of neoplastic development. In: Bannasch P (ed) Cancer diagnosis. Early detection. Springer, Berlin Heidelberg New York, pp 178–190

    Google Scholar 

  40. Baserga R, Porcu P, Sell C (1993) Oncogenes, growth factors and control of the cell cycle. In: Lemoine NR, Wright NA (eds) The molecular pathology of cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 201–213

    Google Scholar 

  41. Beasley RP (1982) Hepatitis B virus as the etiologic agent in hepatocellular carcinoma — epidemiologic consideration. Hepatology 2:215–265

    Google Scholar 

  42. Beasley RP (1988) Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61:1942–1956

    Google Scholar 

  43. Beasley RP, Hwang L-Y (1984) Epidemiology of hepatocellular cancer. In: Vyas GN (ed) Viral hepatitis and liver disease. Grune and Stratton, New York, pp 209–224

    Google Scholar 

  44. Beasley RP, Lin CC, Hwang L-Y, Chien CS (1981) Hepatocellular carcinomas and hepatitis B virus: A prospective study of 22707 men in Taiwan. Lancet 2:1129–1133

    Google Scholar 

  45. Beer DG, Pitot HC (1987) Biological markers characterizing the development of preneoplastic and neoplastic lesions in rodents. Mouse liver tumors. Arch Toxicol Suppl 10:68–80

    Google Scholar 

  46. Bennoun M, Rissel M, Engelhardt N, Guillouzo A, Briand P, Weber-Benarous A (1993) Oval cell proliferation in early stages of hepatocarcinogenesis in Simian Virus 40 large T transgenic mice. Am J Pathol 143:1326–1336

    Google Scholar 

  47. Berenblum J (1985) Changing trends in carcinogenesis. In: Santi L, Zardi L (eds) Theories and models in cellular transformation. Academic Press, London, pp 135–153

    Google Scholar 

  48. Bisgaard HC, Nagy P, Ton PT, Hu Z, Thorgeirsson SS (1994) Modulation of keratin 14 and α-fetoprotein expression during hepatic oval cell proliferation and liver regeneration. J Cell Physiol 159:475–484

    Google Scholar 

  49. Bisgaard HC, Ton PT, Nagy P, Thorgeirsson SS (1994) Phenotypic modulation of keratins, vimentin, and α-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene and spontaneous transformation. J Cell Physiol 159:485–494

    Google Scholar 

  50. Bishop JM (1989) Viruses, genes and cancer. Am Zool 29:653–666

    Google Scholar 

  51. Bonino F, Brunetto MR, Negro F, Smedile A, Ponzetto A (1991) Hepatititis Delta virus, a model of liver cell pathology. J Hepatol 13:260–266

    Google Scholar 

  52. Bosch FX, Muñoz N (1989) Epidemiology of hepatocellular carcinoma. In: Liver cell cancer. Falk Symposium 51. Kluwer Academic Publishers, Dordrecht, pp 3–14

    Google Scholar 

  53. Bowden GT (1990) Oncogene activation during multi-stage carcinogenesis. In: Mendelsohn ML (ed) Mutation and the environment, Part D. Wiley-Liss, New York, pp 1–12

    Google Scholar 

  54. Boyd JA, Barrett JC (1990) Genetic and cellular basis of multistep carcinogenesis. Pharmacol Ther 46:469–486

    Google Scholar 

  55. Bréchot C, Pourcel C, Louise A, Rain B, Tiollais P (1980) Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286:533–535

    Google Scholar 

  56. Bright JJ, Khar A (1994) Apoptosis: Programmed cell death in health and disease. Biosci Rep 14:67–81

    CAS  PubMed  Google Scholar 

  57. Buendia MA (1992) Hepatitis B virus and hepatocellular carcinoma. Adv Cancer Res 58:167–226

    Google Scholar 

  58. Burns FJ (1990) Promotion and progression in carcinogenesis. In: Mendelsohn ML (ed) Mutation and the environment, Part D. Wiley-Liss, New York, pp 65–80

    Google Scholar 

  59. Bursch W, Oberhammer F, Schulte-Hermann R (1992) Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 13:245–251

    Article  CAS  PubMed  Google Scholar 

  60. Burt AD, MacSween RNM (1993) Bile-duct proliferation — its true significance? Histopathology 23:599–602

    Google Scholar 

  61. Cameron RG, Greig PD, Farber E, Wilson S, Sherman M, Levy GA, Phillips MJ (1993) Small encapsulated hepatocellular carcinoma of the liver. Provisional analysis of pathogenetic mechanisms. Cancer 72:2550–2559

    Google Scholar 

  62. Campbell TC, Chen J, Liu C, Li J, Parpia B (1990) Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People's Republic of China. Cancer Res 50:6882–6893

    Google Scholar 

  63. Cerutti PA (1988) Tumor promotion by oxidants. In: Iversen OH (ed) Theories of carcinogenesis. Hemisphere Publishing, Washington, pp 221–229

    Google Scholar 

  64. Charlotte F, L'Herminé A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES (1994) Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 144:460–465

    Google Scholar 

  65. Clark WH (1991) Tumour progression and the nature of cancer. Br J Cancer 64:631–644

    Google Scholar 

  66. Cline MJ (1989) Molecular diagnosis of human cancer. Lab Invest 61:368–380

    Google Scholar 

  67. Coe JE, Ishak KG, Ross MJ (1990) Estrogen induction of hepatocellular carcinomas in Armenian hamsters. Hepatology 11:570–577

    Google Scholar 

  68. Cohen C, DeRose PB (1994) Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia. Mod Pathol 7:536–539

    Google Scholar 

  69. Cohen SM, Ellwein LB (1990) Cell proliferation in carcinogenesis. Science 249:1007–1011

    Google Scholar 

  70. Cohen SM, Ellwein LB (1991) Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 51:6493–6505

    Google Scholar 

  71. Coleman WB, Wennerberg AE, Smith GJ, Grisham JW (1993) Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment. Am J Pathol 142:1373–1382

    Google Scholar 

  72. Colombo M (1992) Hepatocellular carcinoma. J Hepatol 15:225–236

    Google Scholar 

  73. Conway JG, Cattley RC, Popp JA, Butterworth BE (1989) Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate. Drug Metab Rev 21(1):65–102

    Google Scholar 

  74. Cova L, Wild CP, Mehrotra R, Turusov V, Shirai T, Lambert V, Jacquet C, Tomatis L, Trépo C, Montesano R (1990) Contribution of aflatoxin B1 and hepatitis B virus in the induction of liver tumors in ducks. Cancer Res 50:2156–2163

    Google Scholar 

  75. Cova L, Mehrotra R, Wild CP, Chutimataewin S, Cao SF, Duflot A, Prave M, Yu SZ, Montesano R, Trépo C (1994) Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in domestic Chinese ducks. Br J Cancer 69:104–109

    Google Scholar 

  76. Cox PM, Goding CR (1991) Transcription and cancer. Br J Cancer 63:651–662

    Google Scholar 

  77. Cramer JW, Miller JA, Miller EC (1960) N-hydroxylation: a new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluorence. J Biol Chem 235:885–888

    Google Scholar 

  78. Craske J (1992) Hepatitis C and non-A non-B hepatitis revisited: hepatitis E, F and G. J Infect 25:243–250

    Google Scholar 

  79. Cucinotta FA, Wilson JW (1994) An initiation-promotion model of tumour prevalence from high-charge and energy radiations. Phys Med Biol 39:1811–1831

    Google Scholar 

  80. Cullen JM, Sandgren EP, Brinster RL, Maronpot RR (1993) Histologic characterization of hepatic carcinogenesis in transgenic mice expressing SV40 T-antigens. Vet Pathol 30:111–118

    Google Scholar 

  81. Culotta E, Koshland DE Jr. (1993) p53 sweeps through cancer research. Science 262:1958–1961

    Google Scholar 

  82. Cunningham ME, Evans JG, Butler WH (1991) An ultrastructural study of spontaneous and phenobarbitone-induced nodules in mouse liver. Int J Exp Path 72:695–703

    Google Scholar 

  83. Dargel R (1992) Lipid peroxidation — a common pathogenetic mechanism? Exp Toxicol Pathol 44:169–181

    Google Scholar 

  84. DeFlora S, Bennicelli C, Camoirano A, Izzotti A, Hietanen E, Bartsch H, Picciotto A, Millman I (1990) Metabolic activation of food hepatocarcinogens in heptitis B virus-infected humans and animals. In: Pariza MW, Felton JS, Aeschbacher H-U, Sato S (eds) Mutagens and carcinogens in the diet. Wiley Liss, New York, pp 167–182

    Google Scholar 

  85. Deugnier YM, Guyader D, Crantock L, Lopez J-M, Turlin B, Yaouang J, Jouanolle H, Campion J-P, Launois B, Halliday JW, Powell LW, Brissot P (1993) Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 104:228–234

    Google Scholar 

  86. Diamantis ID, McGandy C, Chen T-J, Liaw Y-F, Gudat F, Bianchi L (1994) A new mutational hot-spot in the p53 gene in human hepatocellular carcinoma. J Hepatol 20:553–556

    Google Scholar 

  87. Dienes HP (1992) Die Aussagekraft von Leberbiopsien bei viraler und autoimmuner Hepatitis. Verdauungskrankh 10:76–83

    Google Scholar 

  88. Diwan BA, Ward JM, Rice JM (1991) Modification of liver tumor development in rodents. Prog Exp Tumor Res 33:76–107

    Google Scholar 

  89. Dragan YP, Pitot HC (1992) The role of the stages of initiation and promotion in phenotypic diversity during hepatocarcinogenesis in the rat. Carcinogenesis 13:739–750

    Google Scholar 

  90. Dragan YP, Sargent L, Xu Y-D, Xu Y-H, Pitot HC (1993) The initiation-promotion-progression model of rat hepatocarcinogenesis. Proc Soc Exp Biol Med 202:16–24

    Google Scholar 

  91. Dubois N, Bennoun M, Allemand I, Molina T, Grimber G, Daudet-Monsac M, Abelanet R, Briand P (1991) Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice. J Hepatol 13:227–239

    Google Scholar 

  92. Dunsford HA, Sell S, Chisari FV (1990) Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res 50:3400–3407

    Google Scholar 

  93. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 7:462–503

    PubMed  Google Scholar 

  94. Eggel H (1901) Über das primäre Carcinom der Leber. Inaugural Dissertation, Munich

  95. Eguchi A, Nakashima O, Okudaira S, Sugihara S, Kojiro M (1992) Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma. Hepatology 15:843–848

    Google Scholar 

  96. Elmore LW, Sirica AE (1992) Sequential appearance of intestinal mucosal cell types in the right and caudate liver lobes of furan-treated rats. Hepatology 16:1220–1226

    Google Scholar 

  97. Emmelot P, Scherer E (1980) The first relevant cell stage in rat liver carcinogenesis. A quantitative approach. Biochim Biophys Acta 605:247–304

    Google Scholar 

  98. Enomoto K, Takahashi H, Mori M (1992) A new rat model for the study of hepatocarcinogenesis. J Gastroenterol Hepatol 7:98–104

    Google Scholar 

  99. Eriksson LC, Andersson GN (1992) Membrane biochemistry and chemical carcinogenesis. Crit Rev Biochem Mol Biol 27(1/2):1–55

    Google Scholar 

  100. Eriksson LC, Rinaudo JAS, Farber E (1989) Kinetics of 2-acetylaminofluorene with normal liver and carcinogen-induced hepatocyte nodules in vivo and in vitro. Lab Invest 60:409–417

    Google Scholar 

  101. Esumi M, Shikata T (1994) Hepatitis C virus and liver diseases. Pathol Int 44:85–95

    Google Scholar 

  102. Evans JG, Collins MA, Savage SA, Lake BG, Butler WH (1986) The histology and development of hepatic nodules in C3H/He mice following chronic administration of phenobarbitone. Carcinogenesis 7:627–631

    Google Scholar 

  103. Evans JG, Collins MA, Lake BG, Butler WH (1992) The histology and development of hepatic nodules and carcinoma in C3H/He and C5/BL/6 mice following chronic phenobarbitone administration. Toxicol Pathol 20:585–594

    Google Scholar 

  104. Evarts RP, Hu Z, Fujio K, Marsden ER, Thorgeirsson SS (1993) Activation of hepatic stem cell compartment in the rat: Role of transforming growth factor α, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth Differ 4:555–561

    Google Scholar 

  105. Eyken P van, Desmet VJ (1992) Development of intrahepatic bile ducts, ductular metaplasia of hepatocytes, and cytokeratin patterns in various types of human hepatic neoplasms. In: Sirica AE (ed) The role of cell types in hepatocarcinogenesis. CRC Press, Boca Raton pp 227–263

    Google Scholar 

  106. Factor VM, Radaeva SA, Thorgeirsson SS (1994) Origin and fate of oval cells in Dipin-induced hepatocarcinogenesis in the mouse. Am J Pathol 145:409–422

    Google Scholar 

  107. Farber E (1968) Biochemistry of carcinogenesis. Cancer Res 28:1859–1869

    Google Scholar 

  108. Farber E (1978) Experimental carcinogenesis: A perspective. In: Remmer H, Bolt HM, Bannasch P, Popper H (eds) Primary liver tumors. Falk Symposium 25. MTP Press, Lancaster, pp 357–375

    Google Scholar 

  109. Farber E (1980) The sequential analysis of liver cancer. Biochim Biophys Acta 605:149–166

    Google Scholar 

  110. Farber E (1984) Pre-cancerous steps in carcinogenesis. Their physiological adaptive nature. Biochim Biophys Acta 738:171–180

    Google Scholar 

  111. Farber E (1984) The multistep nature of cancer development. Cancer Res 44:4217–4223

    Google Scholar 

  112. Farber E (1984) Cellular biochemistry of the stepwise development of cancer with chemicals. Cancer Res 44:5463–5474

    Google Scholar 

  113. Farber E (1987) Liver cell cancer: Insights into the pathogenesis of hepatocellular carcinoma in humans from experimental hepatocarcinogenesis in the rat. In: Farber E, Phillips MJ Kaufman N (eds) Pathogenesis of liver diseases. Williams and Wilkins, Baltimore, pp 199–222

    Google Scholar 

  114. Farber E (1987) Experimental induction of hepatocellular carcinoma as a paradigm for carcinogenesis. Clin Physiol Biochem 5:152–159

    Google Scholar 

  115. Farber E (1991) Clonal adaptation as an important phase of hepatocarcinogenesis. Cancer Biochem Biophys 12:157–165

    Google Scholar 

  116. Farber E (1992) Hepatocarcinogenesis: How do peroxisome proliferators relate? J Am Coll Toxicol 11:363–367

    Google Scholar 

  117. Farber E (1992) On cells of origin of liver cell cancer. In: Sirica AE (ed) The role of cell types in hepatocarcinogenesis. CRC Press, Boca Raton, pp 1–28

    Google Scholar 

  118. Farber E (1994) Programmed cell death: Necrosis versus apoptosis. Mod Pathol 7:605–609

    Google Scholar 

  119. Farber E, Cameron R (1980) The sequential analysis of cancer development. Adv Cancer Res 31:125–225

    Google Scholar 

  120. Farber E, Ichinose H (1959) On the origin of malignant cells in experimental liver cancer. Acta Unio Intern Contra Cancrum 15:152–153

    Google Scholar 

  121. Farber E, Rubin H (1991) Cellular adaptation in the origin and development of cancer. Cancer Res 51:2751–2761

    Google Scholar 

  122. Farber E, Sarma DSR (1986) Chemical carcinogenesis. The liver as a model. Pathol Immunopathol Res 5:1–28

    Google Scholar 

  123. Farber E, Sarma DSR (1987) Chemical carcinogenesis: The liver as a model. In: Maskens AP, Ebbesen P, Burny A (eds) Concepts and theories in carcinogenesis. Elsevier, Amsterdam, pp 185–220

    Google Scholar 

  124. Farber E, Sarma DSR (1987) Hepatocarcinogenesis: A dynamic cellular perspective. Lab Invest 56:4–22

    Google Scholar 

  125. Farber E, Chen Z-Y, Harris L, Lee G, Rinaudo JS, Roomi WM, Rofstein J, Semple E (1989) The biochemical-molecular pathology of the stepwise development of cancer: New insights and problems. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Falk Symposium 51. Kluwer Academic Publishers, Dordrecht, pp 275–291

    Google Scholar 

  126. Farber JL, Kyle ME, Coleman JB (1990) Mechanisms of cell injury by activated oxygen species. Lab Invest 62:670–679

    Google Scholar 

  127. Feitelson MA (1992) Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev 5:275–301

    Google Scholar 

  128. Feitelson MA (1994) Biology of hepatitis B virus variants. Lab Invest 71:324–349

    Google Scholar 

  129. Ferrell LD, Wright T, Lake J, Roberts J, Ascher N (1992) Incidence and diagnostic features of macroregenerative nodules vs. small heaptocellular carcinoma in cirrhotic livers. Hepatology 16:1372–1381

    Google Scholar 

  130. Ferrell LD, Crawford JM, Dhillon AP, Scheuer PJ, Nakanuma Y (1993) Proposal for standardized criteria for the diagnosis of benign, borderline and malignant hepatocellular lesions arising in chronic and advanced liver disease. Am J Surg Pathol 17:1113–1123

    Google Scholar 

  131. Fitzgerald DJ, Mesnil M, Oyamada M, Tsuda H, Ito N, Yamasaki H (1989) Changes in gap junction protein (connexin 32) gene expression during rat liver carcinogenesis. J Cell Biochem 41:97–102

    Google Scholar 

  132. Floyd RA (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4:2587–2597

    Google Scholar 

  133. Franco D, Castain D, Bréchot C, Morin J (1982) L'aflatoxine B1, est-elle un carcinogène hépatique chez l'homme? Gastroenterol Clin Biol 6:125–128

    Google Scholar 

  134. Freeman CS, Kimes BW, Martin MR, Marks CL (1989) An overview of tumor biology. Cancer Invest 7:247–265

    Google Scholar 

  135. Friedewald WF, Rous P (1944) The initiating and promoting elements in tumor production. An analysis of the effects of tar, benzpyrene, and methylcholanthrene on rabbit skin. J Exp Med 80:101–126

    Google Scholar 

  136. Friedrich-Freska H, Papadopulu G, Gössner W (1969) Histochemische Untersuchungen der Cancerogenese in der Rattenleber nach zeitlich begrenzter Verabfolgung von Diäthylnitrosamin. Z Krebsforschung 72:240–253

    Google Scholar 

  137. Frommel D, Crevat D, Vitvitsky L, Pichoud C, Hautz O, Chevalier M, Grimaud J-A, Lindberg J, Trépo CG (1984) Immunopathologic aspects of woodchuck hepatitis. Am J Pathol 115:125–134

    Google Scholar 

  138. Fujio K, Evarts RP, Hu Z, Marsden ER, Thorgeirrson SS (1994) Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest 70:511–516

    Google Scholar 

  139. Furuya K, Nakamura M, Yamamoto Y, Togei K, Otsuka H (1988) Macroregenerative nodule of the liver. A clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer 61:99–105

    Google Scholar 

  140. Gallagher JT (1985) The cell-surface membrane in malignancy. In: Farmer PB, Walker JM (eds) The molecular basis of cancer. Croom Helm, London, pp 37–69

    Google Scholar 

  141. Geller SA, Nichols WS, Kim S, Tolmachoff I, Lee S, Dycaico MJ, Felts K, Sorge JA (1994) Hepatocarcinogenesis is the sequel to hepatitis in Z#2 α1-antitrypsin transgenic mice: Histopathological and DNA ploidy studies. Hepatology 19:389–397

    Google Scholar 

  142. Gerbes AL, Caselmann WH (1993) Point mutations of the p53 gene, human hepatocellular carcinoma and aflatoxins. J Hepatol 19:312–315

    Google Scholar 

  143. Gerbracht U, Eigenbrodt E, Simile MM, Pascale RM, Gaspa L, Daino L, Seddain MA, DeMiglio MR; Nufris A, Feo F (1993) Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. Anticancer Res 13:1965–1972

    Google Scholar 

  144. Gerlyng P, Grotmol T, Stokke T, Erikstein B, Seglen PO (1994) Flow cytometric investigation of a possible precursor-product relationship between oval cells and parenchymal cells in the rat. Carcinogenesis 15:53–59

    Google Scholar 

  145. Gerok W, Blum HE, Offensperger S, Andus T, Gross V, Heinrich PC (1991) Neuere Forschungsergebnisse in ihrer Bedeutung für das Verständnis von Leberkrankheiten. Naturwissenschaften 78:241–249

    Google Scholar 

  146. Ghoshal AK, Farber E (1993) Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: A new perspective. Lab Invest 68:255–260

    Google Scholar 

  147. Gibson GG (1993) Peroxisome proliferators: Paradigms and prospects. Toxicol Lett 68:193–201

    Google Scholar 

  148. Goldblum JR, Bartos RE, Carr KA, Frank TS (1993) Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma. Am J Surg Pathol 17:1244–1251

    Google Scholar 

  149. Goldfarb S, Pugh TD (1992) Histogenesis and pathobiology of mouse hepatocellular neoplasms. In: Sirica AE (ed) The role of cell types in hepatocarcinogenesis. CRC Press, Boca Raton, pp 55–69

    Google Scholar 

  150. Goldstein BD, Witz G (1990) Free radicals and carcinogenesis. Free Radic Res Commun 11:3–10

    Google Scholar 

  151. Goldworthy TL, Hanigan MH, Pitot HC (1986) Models of hepatocarcinogenesis in the rat. Contrasts and comparisons. Crit Rev Toxicol 17:61–89

    Google Scholar 

  152. Goodman JI, Ward JM, Popp JA, Klaunig JE, Fox TR (1991) Mouse liver carcinogenesis: Mechanisms and relevance. Fundam Appl Toxicol 17:651–665

    Google Scholar 

  153. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology. Cancer Res 54:4855–4878

    CAS  PubMed  Google Scholar 

  154. Grisham JW (1994) Migration of hepatocytes along hepatic plates and stem cell-fed hepatocyte lineages. Am J Pathol 144:849–854

    Google Scholar 

  155. Guengerich FP (1992) Metabolic activation of carcinogens. Pharmacol Ther 54:17–61

    Google Scholar 

  156. Guyton KZ, Kensler TW (1993) Oxidative mechanisms in carcinogenesis. Br Med Bull 49:523–544

    Google Scholar 

  157. Halliwelll B, Aruoma OI (1991) DNA damage by oxygenderived species. Its mechanism and measurement in mammalian systems. FEBS Lett 28:9–19

    Google Scholar 

  158. Harris CC (1991) Chemical and physical carcinogenesis: Advances and perspectives for the 1990's. Cancer Res [Suppl]51:5023s-5044s

    Google Scholar 

  159. Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318–1327

    Google Scholar 

  160. Harris L, Morris LE, Farber E (1989) Protective value of a liver initiation-promotion regimen against the lethal effect of carbon tetrachloride in rats. Lab Invest 61:467–470

    Google Scholar 

  161. Hasegawa R, Ito N (1994) Hepatocarcinogenesis in the rat. In: Waalkes MP, Ward JM (eds) Carcinogenesis. Raven Press, New York, pp 39–65

    Google Scholar 

  162. Hayward NK, Walker GJ, Graham W, Cooksley E (1991) Hepatocellular carcinoma mutation. Nature 352:764

    Google Scholar 

  163. Helman LJ, Thiele CJ (1991) New insights into the cause of cancer. Pediatr Clin North Am 38:201–221

    Google Scholar 

  164. Heukelom S van (1894) Das Adeno-Carcinom der Leber mit Cirrhose. Beitr Pathol Anat 16:341–387

    Google Scholar 

  165. Heger I (1959) Theories of carcinogenesis. In: Wolstenholme CEW, O'Connor CM (eds) CIBA Foundation Symposium on carcinogenesis. Churchill, London, pp 3–11

    Google Scholar 

  166. Higgins GK (1970) The pathologic anatomy of primary hepatic tumors. Recent Results Cancer Res 26:15–37

    Google Scholar 

  167. Hirota N, Williams GM (1979) Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure. J Natl Cancer Int 63:1257–1265

    Google Scholar 

  168. Hixson DC, Faris RA, Yang L, Novikoff P (1992) Antigenic clues to liver development, renewal, and carcinogenesis: An integrated model. In: Sirica AE (ed) The role of cell types in hepatocarcinogenesis. CRC Press, Boca Raton, pp 151–182

    Google Scholar 

  169. Höhne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich W (1990) Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 9:1137–1145

    Google Scholar 

  170. Höhne MW, Zieroth S, Veser U, Kahl GF, Schwarz LR (1993) Carcinogen-induced diploid hepatocytes: Sensitive target cells for transformation by mutated c-Ha-ras oncogene. Mol Carcinog 7:180–189

    Google Scholar 

  171. Hollingsworth RE, Lee W-H (1991) Tumor suppressor genes: New prospects for cancer research. J Natl Cancer Inst 83:91–96

    Google Scholar 

  172. Hsia CC, Kleiner DE Jr, Axiotis CA, Di Bisceglie A, Nomura AMY, Stemmermann GN, Tabor E (1992) Mutations of p53 gene in hepatocellular carcinoma: Roles of hepatitis B virus and aflatoxin contamination in the diet. J Natl Cancer Inst 84:1638–1641

    Google Scholar 

  173. Hsu H-C, Chiou T-J, Chen J-Y. Lee C-S, Lee P-H, Peng S-Y (1991) Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology 13:923–928

    Google Scholar 

  174. Huff JE, Eustis SL, Haseman JK (1989) Occurrence and relevance of chemically induced benign neoplasms in long-term carcinogenicity studies. Cancer Metastasis Rev 8:1–21

    Google Scholar 

  175. Hully JR, Su Y, Lohse JK, Griep AE, Sattler CA, Haas MJ, Dragan Y, Peterson J, Neveu M, Pitot HC (1994) Transgenic hepatocarcinogenesis in the rat. Am J Pathol 145:384–397

    Google Scholar 

  176. Iannaccone PM, Weinberg WC, Deamant FD (1987) On the clonal origin of tumors: A review of experimental models. Int J Cancer 39:778–784

    Google Scholar 

  177. Ishak KG (1987) New developments in diagnostic liver pathology. In: Farber E, Phillips MJ, Kaufman N (eds) Pathogenesis of liver diseases. Williams and Wilkins, Baltimore, pp 223–373

    Google Scholar 

  178. Ito N, Imaida K, Hasegawa R, Tsuda H (1989) Rapid bioassay method for carcinogens and modifiers of hepatocarcinogenesis. Crit Rev Toxicol 19:385–415

    Google Scholar 

  179. Iversen OH (1988) Initiation, promotion: Critical remarks on the two-stage theory. In: Iversen OH (ed) Theories of carcinogenesis. Hemisphere Publishing, Washington, pp 119–126

    Google Scholar 

  180. Jackson MA, Stack HF, Waters MD (1993) The genetic toxicology of putative nongenotoxic carcinogens. Mutat Res 296:241–277

    Google Scholar 

  181. Jang J-J, Weghorst CM, Henneman JR, Devor DE, Ward JM (1992) Progressive atypia in spontaneous and N-nitrosodiethylamine-induced hepatocellular adenomas of C3H/HeNCr mice. Carcinogenesis 13:1541–1547

    Google Scholar 

  182. Johnson M, Koukoulis G, Matsumoto K, Nakamura T, Iyer A (1993) Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells. Hepatology 17:1052–1061

    Google Scholar 

  183. Kalayci C, Johnson PJ, Davies SE, Williams R (1991) Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol 12:54–59

    Google Scholar 

  184. Kehrer P (1993) Free radicals as mediators of tissue injury and diseases. Crit Rev Toxicol 23:21–48

    Google Scholar 

  185. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257

    CAS  PubMed  Google Scholar 

  186. Kew MC (1986) The development of hepatocellular cancer in humans. Cancer Surv 5:719–739

    Google Scholar 

  187. Kew MC (1994) Hepatitis C virus and hepatocellular carcinoma. FEMS Microbiol Rev 14:211–220

    Google Scholar 

  188. Kharsa G, Degott C, Filoche B, Hedde JP, Pofet F, Benhamou JP (1990) Adénome hépatique et carcinome hépatocellulaire chez deux frères atteints de glycogénose de type I. Gastroenterol Clin Biol 14:84–85

    Google Scholar 

  189. Kin M, Torimura T, Ueno T, Inuzuka S, Tanikawa K (1994) Sinusoidal capillarization in small hepatocellular carcinoma. Pathol Int 44:771–778

    Google Scholar 

  190. Kirby GM, Chemin I, Montesano R, Chisari FV, Lang MA, Wild CP (1994) Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice. Mol Carcinog 11:74–80

    Google Scholar 

  191. Klaunig JE (1991) Alterations in intercellular communication during the stage of promotion. Proc Soc Exp Biol Med 198:688–692

    Google Scholar 

  192. Klaunig JE, Ruch RJ (1990) Role of inhibition of intercellular communication in carcinogenesis. Lab Invest 62:135–146

    Google Scholar 

  193. Klein G (1981) The role of gene dosage and genetic transpositions in carcinogenesis. Nature 294:313–318

    Google Scholar 

  194. Klencke PFH (1843) Untersuchungen und Erfahrungen im Gebiete der Anatomie, Pathologie, Mikrologie und wissenschaftlichen Medizin, vols. 1 and 2. Leipzig, 1843. [Cited by Rather LJ (1978) The genesis of cancer. A study in the history of ideas. Johns Hopkins University Press, Baltimore]

  195. Kondo F, Hirooka N, Wada K, Kondo Y (1987) Morphological clues for the diagnosis of small hepatocellular carcinomas. Virchows Arch [A] 411:15–21

    Google Scholar 

  196. Kondo F, Wada K, Kondo Y (1988) Morphometric analysis of hepatocellular carcinoma. Virchows Arch [A] 413:425–430

    Google Scholar 

  197. Kondo Y, Niwa Y, Akikusa B, Takazawa H, Okabayashi A (1983) A histopathologic study of early hepatocellular carcinoma. Cancer 52:687–692

    Google Scholar 

  198. Kondo Y, Kondo F, Wada K, Okabayshi A (1986) Pathologic features of small hepatocellular carcinoma. Acta Pathol Jpn 36:1149–1161

    Google Scholar 

  199. Koshy R, Meyer M (1992) Oncogenicity of hepatitis B virus. Rev Med Virol 2:131–140

    Google Scholar 

  200. Kraupp-Grasl B, Huber W, Putz B, Gerbracht U, Schulte-Hermann R (1990) Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Cancer Res 50:3701–3708

    Google Scholar 

  201. Kraupp-Grasl B, Huber W, Taper H, Schulte-Hermann R (1991) Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator Nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res 51:666–671

    Google Scholar 

  202. Krutovskikh V, Oyamada M, Yamasaki H (1991) Sequential changes of gap-junctional intercellular communications during multistage rat liver carcinogenesis: Direct measurement of communication in vivo. Carcinogenesis 12:1701–1706

    Google Scholar 

  203. Kuo MT (1993) Expression of multidrug-resistance (P-glycoprotein) genes in liver cancers: A molecular example of the convergence theory of hepatocarcinogenesis? Mol Carcinog 7:73–75

    Google Scholar 

  204. LaBrecque DR (1992) Neoplasia of the liver. In: Kaplowitz N (ed) Liver and biliary diseases. Williams and Wilkins, Baltimore, pp 347–388

    Google Scholar 

  205. Lack EE, Neave C, Vawter GF (1983) Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 52:1510–1515

    Google Scholar 

  206. Lake BG, Evans JG, Cunningham ME, Price RJ (1993) Comparison of the hepatic effects of nafenopin and Wy-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster. Environ Health Perspect [Suppl] 101:241–247

    Google Scholar 

  207. Lea MA (1993) Regulation of gene expression in hepatomas. Int J Biochem 25:457–469

    Google Scholar 

  208. Ledda-Columbano G, Columbano A (1991) Apoptosis and hepatocarcinogenesis. In: Tomei LD, Cope FO (eds) Apoptosis: The molecular basis of cell death. Current communications, number 3. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 101–119

    Google Scholar 

  209. Lee VM, Cameron RG, Archer MC (1993) The role of hepatocyte heterogeneity in the initiation of hepatocarcinogenesis. Carcinogenesis 14:1403–1408

    Google Scholar 

  210. Lijinsky W (1989) A view of the relation between carcinogenesis and mutagenes. Environ Mol Mutagen [Suppl] 16:78–84

    Google Scholar 

  211. Lijinsky W (1990) Non-genotoxic environmental carcinogens. Environ Carcinog Rev (J Environ Sci Health [8]) C.8(8):45–87

    Google Scholar 

  212. Limmer J, Fleig WE, Leupold D, Bittner R, Ditschuneit H, Beger H-G (1988) Hepatocellular carcinoma in Type I glycogen storage disease. Hepatology 8:531–537

    Google Scholar 

  213. Loeb LA (1989) Endogenous carcinogenesis: Molecular oncology into the twenty first century. Cancer Res 49:5489–5496

    Google Scholar 

  214. Lohiya G, Pirkle H, Hoefs J, Lohiya S, Ngo VT (1985) Hepatocellular carcinoma in young mentally retarded HBsAg carriers without cirrhosis. Hepatology 5:824–826

    Google Scholar 

  215. London WT, Kitagawa T (1987) Summary of the U.S.-Japan Workshop on hepatitis B virus and primary hepatocellular carcinoma, January 29–30, 1987. Jpn J Cancer Res 78:869–874

    Google Scholar 

  216. Lotze MT, Flickinger JC, Carr BI (1993) Hepatobiliary neoplasms. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: Principles and practice of oncology, 4th edn, vol. I. J.B. Lippincott, Philadelphia, pp 883–914

    Google Scholar 

  217. Lutwick LI (1979) Relation between aflatoxin, hepatitis B virus, and hepatocellular carcinoma. Lancet 1:755–757

    Google Scholar 

  218. Macara IG (1989) Oncogenes and cellular signal transduction. Physiol Rev 69:797–820

    Google Scholar 

  219. Marceau N (1990) Cell lineages and differentiation programs in epidermal, urothelial and hepatic tissues and their neoplasms. Lab Invest 63:4–20

    Google Scholar 

  220. Marceau N, Blouin M-J, Noël M, Török N, Loranger A (1992) The role of bipotential progenitor cells in liver ontogenesis and neoplasia. In: Sirica AE (ed) The role of cell types in hepatocarcinogenesis. CRC Press, Boca Raton, pp 121–149

    Google Scholar 

  221. Marks F, Fürstenberger G (1988) Multistage carcinogenesis in animal skin: The reductionist's approach in cancer research. In: Iversen OH (ed) Theories of carcinogenesis. Hemisphere Publishing, Washington, pp 179–190

    Google Scholar 

  222. Maronpot RR (1991) Chemical carcinogenesis. In: Haschek W (ed) Handbook of toxicologic pathology, Academic Press, New York, pp 91–129

    Google Scholar 

  223. Maronpot RR, Montgomery CA Jr, Boorman GA, McConnell EE (1986) National Toxicology Program nomenclature for hepatoproliferative lesions of rats. Toxicol Pathol 14:263–273

    Google Scholar 

  224. Martin-Durr X (1891) Cancer avec cirrhose (adénome). Bull Mem Soc Anat (Paris) pp 365–366

  225. Mayer D, Klimek F, Hacker H-J, Seelmann-Eggebert G, Bannasch P (1989) Carbohydrate metabolism in hepatic preneoplasia. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Falk Symposium 51. Kluwer Academic Publishers, Dordrecht, pp 329–345

    Google Scholar 

  226. Melnick RL (1992) Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J 6:2698–2706

    Google Scholar 

  227. Meybehm M, Fischer H-P, Pfeifer U (1993) Expression of HBs- and HBc-antigen in neoductular epithelium in chronic active hepatitis B. Virchows Arch [B] 63:167–172

    Google Scholar 

  228. Miller JA (1994) Brief history of chemical carcinogenesis. Cancer Lett 83:9–14

    Google Scholar 

  229. Miller EC, Miller JA (1966) Mechanisms of chemical carcinogenesis: Nature of proximate carcinogens and interactions with macromolecules. Pharmacol Rev 18:805–838

    Google Scholar 

  230. Mitaka T, Norioka K-I, Mochizuki Y (1993) Redifferentiation of proliferated rat hepatocytes cultured in L15 medium supplemented with EGF and DMSO. In Vitro Cell Dev Biol 29A:714–722

    Google Scholar 

  231. Mitaka T, Norioka K-I, Sattler GL, Pitot HC, Mochizuki Y (1993) Effect of age on the formation of small-cell colonies in cultures of primary rat hepatocytes. Cancer Res 53:3145–3148

    Google Scholar 

  232. Monier R (1990) Oncogenes and anti-oncogenes in tumorigenesis. Reprod Nutr Dev 30:445–454

    Google Scholar 

  233. Moody DE, Reddy JK, Lake BG, Popp JA, Reese DH (1991) Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium. Fundam Appl Toxicol 16:233–248

    CAS  PubMed  Google Scholar 

  234. Moore MA, Kitagawa T (1986) Hepatocarcinogenesis in the rat: The effect of promoters and carcinogens in vivo and in vitro. Int Rev Cytol 101:125–173

    Google Scholar 

  235. Moore MA, Thamavit W, Hiasa Y, Ito N (1988) Early lesions induced by DHPN in Syrian golden hamsters: influence of concommitant Opisthorchis infestation, dehydroepiandrosterone or butylated hydroxyanisole administration. Carcinogenesis 9:1185–1189

    Google Scholar 

  236. Moore MR, Pitot HC, Miller EC, Miller JA (1982) Cholangiocellular carcinomas induced in Syrian golden hamsters administered aflatoxin B1 in large doses. J Natl Cancer Inst 68:271–278

    Google Scholar 

  237. Mufti SI (1991) Liver Cancer. Role of alcohol and other factors. In: Watson RR (ed) Drug and alcohol abuse reviews, vol 2. Liver pathology and alcohol. Humana Press, Totowna, NJ, pp 195–219

    Google Scholar 

  238. Nakanuma Y, Hirata K (1993) Unusual hepatocellular lesions in primary biliary cirrhosis resembling but unrelated to hepatocellular neoplasms. Virchows Arch [A] 422:17–23

    Google Scholar 

  239. Nakanuma Y, Terada T, Terasaki S, Ueda K, Nonomura A, Kawahara E, Matsui O (1990) ‘Atypical adenomatous hyperplasia’ in liver cirrhosis: low-grade hepatocellular carcinoma or borderline lesion? Histopathology 17:27–35

    Google Scholar 

  240. Nakanuma Y, Terada T, Ueda K, Terasaki S, Nonomura A, Matsui O (1993) Adenomatous hyperplasia of the liver as a precancerous lesion. Liver 13:1–9

    Google Scholar 

  241. Nalpas B, Driss F, Pol S, Hamelin B, Housset C, Bréchot C, Berthelot P (1991) Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 12:70–74

    Google Scholar 

  242. Nicolson GL (1987) Tumor cell instability, diversification and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res 47:1473–1487

    Google Scholar 

  243. Ober S, Zerban H, Spiethoff A, Wegener K, Schwarz M, Bannasch P (1994) Preneoplastic foci of altered hepatocytes induced in rats by irradition with α-particles of thorotrast and neutrons. Cancer Lett 83:81–88

    Google Scholar 

  244. Oberley TD, Slattery AF, Gonzalez A, Li SA, Li JJ (1991) Comparative morphologic and immunohistochemical studies of estrogen plus alpha-naphthoflavone-induced liver tumors in Syrian hamsters and rats. Am J Pathol 139:669–679

    Google Scholar 

  245. Ohkoshi S, Kato N, Kinoshita T, Hijikata M, Ohtnsuyama Y, Okazaki N, Ohkura H, Hirohashi S, Honma A, Ozaki T, Yoshikawa A, Kojima H, Asakura H, Shimotohno K (1990) Detection of hepatitis C virus RNA in sera and liver tissues of non-A, non-B hepatitis patients using the polymerase chain reaction. Jpn J Cancer Res 81:862–865

    Google Scholar 

  246. Ohno T, Shiga J, Machinami R (1990) A histopathological analysis of five cases of adenomatous hyperplasia containing minute hepatocellular carcinoma. Acta Pathol Jpn 40:267–278

    Google Scholar 

  247. Okuda K (1992) Hepatocellular carcinoma: Recent progress. Hepatology 15:948–963

    Google Scholar 

  248. Ozturk M et al. (1991) p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338:1356–1359

    Google Scholar 

  249. Pack R, Heck R, Dienes HP, Oesch F, Steinberg P (1993) Isolation, biochemical characterization, long-term culture, and phenotype modulation of oval cells from carcinogen-fed rats. Exp Cell Res 204:198–209

    Google Scholar 

  250. Page DL (1991) Atypical hyperplasia, narrowly and broadly defined. Hum Pathol 22:631–632

    Google Scholar 

  251. Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606

    Google Scholar 

  252. Pasquinelli C, Bhavani K, Chisari FV (1992) Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res 52:2823–2829

    Google Scholar 

  253. Payet M, Camain R, Pene P (1956) Le cancer primitif du foie; étude critique à propos de 240 cas. Rev Int Hépatol 6:1–86

    Google Scholar 

  254. Peraino C, Richards WL, Stevens FJ (1983) Multistage hepatocarcinogenesis. In: Slaga TJ (ed) Mechanisms of tumor promotion, vol I: Tumor promotion in internal organs. CRC Press, Boca Raton, pp 1–53

    Google Scholar 

  255. Peraino C, Carnes BA, Stevens FJ, Staffeldt EF, Russell JJ, Prapuolenis A, Blomquist JA, Vesselinovitch SD, Maronpot RR (1988) Comparative developmental and phenotypic properties of altered hepatocyte foci and hepatic tumors in rats. Cancer Res 48:4171–4178

    Google Scholar 

  256. Perera FP, Rall DP, Weinstein IB (1991) In response to letters by Ames, B.N. and Gold, L.S., and by Cohen, S.M. and Ellwein, L.B. on “Carcinogenic mechanisms: The debate continues”. Science 252:903–904

    Google Scholar 

  257. Peterson JE (1990) Biliary hyperplasia and carcinogenesis in chronic liver damage induced in rats by phomopsin. Pathology 22:213–222

    Google Scholar 

  258. Pitot HC (1989) The molecular determinant of carcinogenesis: A symposium sketch. In: Becker FF, Slaga TJ (eds) Symposium on fundamental cancer research, vol 39. University of Texas System Cancer Center, Texas, pp 187–196

    Google Scholar 

  259. Pitot HC (1989) Progression: The terminal stage in carcinogenesis. Jpn J Cancer Res 80:599–607

    Google Scholar 

  260. Pitot HC (1990) Altered hepatic foci: Their role in murine hepatocarcinogenesis. Annu Rev Pharmacol Toxicol 30:465–500

    Google Scholar 

  261. Pitot HC (1991) Endogenous carcinogenesis: The role of tumor promotion. Proc Soc Exp Biol Med 198:661–666

    Google Scholar 

  262. Pitot HC, Dragan YP (1994) The multistage nature of chemically induced hepatocarcinogenesis in the rat. Drug Metab Rev 26:209–220

    Google Scholar 

  263. Pitot HC, Sirica AE (1980) The stages of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta 605:191–215

    Google Scholar 

  264. Pitot HC, Beer D, Hendrich S (1988) Multistage carcinogenesis: The phenomenon underlying the theories. In: Iversen OH (ed) Theoreies of carcinogenesis. Hemisphere Publishing, Washington, pp 159–177

    Google Scholar 

  265. Pitot HC, Dragan Y, Xu Y-H, Pyron M, Laufer C, Rizvi T (1990) Role of altered hepatic foci in the stages of carcinogenesis. In: Mendelsohn ML (ed) Mutation and the environment, part D. Wiley-Liss, New York, pp 81–95

    Google Scholar 

  266. Pitot HC, Dragan Y, Sargent L, Xu Y-H (1991) Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat. Environ Health Perspect 93:181–189

    Google Scholar 

  267. Popper H, Sternberg SS, Oser BC, Oser M (1960) The carcinogenic effect of aramite in rats. A study of hepatic nodules. Cancer 13:1035–1046

    Google Scholar 

  268. Popper H, Purcell RH, Gerlin JL (1987) Histology of hepadna and delta virus-induced hepatitis and hepatocellular carcinoma. In: Robinson W, Koike K, Will H (eds) Hepadna viruses. Alan R. Liss, New York, pp 373–386

    Google Scholar 

  269. Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL (1987) Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 84:866–870

    Google Scholar 

  270. Popper H, Shafritz DA, Hoofnagle JH (1987) Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 7:764–772

    Google Scholar 

  271. Popper H, Thung SN, McMahon BJ, Lanier AP, Hawkins I, Alberts SR (1988) Evolution of hepatocellular carcinoma associated with chronic hepatitis B virus infection in Alaskan Eskimos. Arch Pathol Lab Med 112:498–504

    Google Scholar 

  272. Prehn RT (1994) Cancers beget mutations versus mutations beget cancers. Perspect Cancer Res 54:5296–5300

    Google Scholar 

  273. Purcell RH (1994) Hepatitis C virus: Historical perspective and current concepts. FEMS Microbiol Rev 14:181–192

    Google Scholar 

  274. Purchase IFH (1994) Current knowledge of mechanisms of carcinogenicity: Genotoxins versus non-genotoxins. Hum Exp Toxicol 13:17–28

    Google Scholar 

  275. Rabes HM (1983) Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogens. J Cancer Res Clin Oncol 106:85–92

    Google Scholar 

  276. Rabes HM (1986) DNA adducts and cell cycle. J Cancer Res Clin Oncol 112:189–195

    Google Scholar 

  277. Rabes HM (1989) Cell proliferation and clonal development in hepatocarcinogenesis. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Falk Symposium 51. Kluwer Academic Publishers, Dordrecht, pp 306–313

    Google Scholar 

  278. Rao MS, Reddy JK (1991) An overview of peroxisome proliferator-induced hepatocarcinogenesis. Environ Health Perspect 93:205–209

    Google Scholar 

  279. Rao MS, Dwivedli RS, Subbarao V, Reddy JK (1988) Induction of peroxisome proliferation and hepatic tumours in C57BL/GN mice by ciprofibrate, a hypolipidemic compound. Br J Cancer 58:46–51

    Google Scholar 

  280. Rao MS, Nemali MR, Usuda N, Scarpelli DG, Makino T, Pitot HC, Reddy JK (1988) Lack of expression of glutathione-S-transferase P1 α-glutamyl transpeptidase, and α-fetoprotein messenger RNA's in liver tumors induced by peroxisome proliferators. Cancer Res 48:4919–4925

    Google Scholar 

  281. Reddy JK, Rao MS (1989) Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Mutat Res 214:63–68

    Google Scholar 

  282. Rous P, Kidd JG (1941) Conditional neoplasms and subthreshold neoplastic states. A study of tar tumors in rabbits. J Exp Med 73:365–392

    Google Scholar 

  283. Ruddon RW (1987) Cancer Biology, 2nd edn. Oxford University Press, Oxford

    Google Scholar 

  284. Sakamoto M, Hirohashi S, Shimosato Y (1991) Early steps of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22:172–178

    Google Scholar 

  285. Sarraf C, Lalani E-N, Golding M, Anilkumar TV, Poulsom R, Alison M (1994) Cell behaviour in the acetylaminofluorene-treated regenerating rat liver. Light and electron microscopic observations. Am J Pathol 145:1114–1126

    Google Scholar 

  286. Schaff Z, Lapis K (1990) Fine structure of hepatocytes during the etiology of several common pathologies. J Electron Microsc Tech 14:179–207

    Google Scholar 

  287. Schirmacher P, Rogler CF, Dienes HP (1993) Current pathogenetic and molecular concepts in viral carcinogenesis. Virchows Arch [B] 63:71–89

    Google Scholar 

  288. Schödel F, Sprengel T, Weimer T, Fernholz D, Schneider R, Will H (1989) Animal hepatitis B viruses. Adv Viral Oncol 8:73–102

    Google Scholar 

  289. Schulte-Hermann R (1985) Tumor promotion in the liver. Arch Toxicol 57:147–158

    Google Scholar 

  290. Schulte-Hermann R, Bursch W, Fesus L, Timmermann-Troisier I, Kraupp B, Liehr J (1989) Role of cell death in hepatocarcinogenesis. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Falk Symposium 51. Kluwer Academic Publishers, Dordrecht, pp 347–358

    Google Scholar 

  291. Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W (1990) DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 50:5127–5135

    Google Scholar 

  292. Schulte-Hermann R, Bursch W, Parzefall W (1991) Mitogenesis and programmed cell death as determinants of carcigenicity of nongenotoxic compounds. In: Butterworth BE, Slaga TJ, Farland W, McClain M (eds) Chemically induced cell proliferation: implications for risk assessment. Wiley-Liss, New York, pp 237–244

    Google Scholar 

  293. Schwartzman RA, Cidlowski JA (1993) Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 14:133–151

    Google Scholar 

  294. Scribner JD, Süss R (1978) Tumor initiation and promotion. Int Rev Exp Pathol 18:137–178

    Google Scholar 

  295. Seawright AA, Snowden RT, Olubuyide O, Riley J, Judah DJ, Neal GE (1993) A comparison of the effects of aflatoxin B1 on the livers of rats and duck hepatitis B virus-infected and noninfected ducks. Hepatology 18:188–197

    Google Scholar 

  296. Sell S (1993) Cellular origin of cancer: Dedifferentiation or stem cell maturation arrest? Environ Health Perspect [Suppl] 101:15–26

    Google Scholar 

  297. Sell S (1994) Liver stem cells. Mod Pathol 7:105–112

    Google Scholar 

  298. Sell S, Pierce BG (1994) Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 70:6–22

    Google Scholar 

  299. Sell S, Hunt JM, Knoll BJ, Dunsford HA (1987) Cellular events during hepatocarcinogenesis in rats and the question of premalignancy. Adv Cancer Res 48:37–111

    Google Scholar 

  300. Sell S, Hunt JM, Dunsford HA, Chisari FV (1991) Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice. Cancer Res 51:1278–1285

    Google Scholar 

  301. Selter H, Montenarh M (1994) The emerging picture of p53. Int J Biochem 26:145–154

    Google Scholar 

  302. Sherlock S (1994) Chronic hepatitis C. Dis Mon, vol 40, no 3, pp 119–196

    Google Scholar 

  303. Sherlock S, Fox RA, Niazi SP, Scheuer P (1970) Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet 1:1243–1247

    Google Scholar 

  304. Sheu J-C, Huang G-T, Chou H-C, Lee P-H, Wang J-T, Lee H-S, Chen D-S (1993) Multiple hepatocellular carcinomas at the early stage have different clonality. Gastroenterology 105:1471–1476

    Google Scholar 

  305. Shieh YSC, Nguyen C, Vocal MV, Chu H-W (1993) Tumor suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma. Int J Cancer 54:558–562

    Google Scholar 

  306. Shiojiri N, Mizuno T (1993) Differentiation of functional hepatocytes and biliary epithelial cells from immature hepatocytes of the fetal mouse in vitro. Anat Embryol (Berl) 187:221–229

    Google Scholar 

  307. Shubik P (1984) Progression and promotion. J Natl Cancer Inst 73:1005–1011

    Google Scholar 

  308. Sinkovics JG (1988) Oncogenes and growth factorss. Crit Rev Immunol 8:217–298

    Google Scholar 

  309. Sirica AE, Elmore LW, Williams TW, Cole SL (1992) Differentiation potential of hyperplastic bile ductular epithelial cells in rat models of hepatic injury and cholangiocarcinogenesis. In: Sirica AE (ed) The role of cell types in hepatocarcinogenesis. CRC Press, Boca Raton, pp 183–208

    Google Scholar 

  310. Sirica AE, Gainey TW, Mumaw VR (1994) Ductular hepatocytes. Evidence for a bile ductular cell origin in furantreated rats. Am J Pathol 145:375–383

    Google Scholar 

  311. Slagle BL, Lee T-H, Butel JS (1992) Hepatitis B virus and hepatocellular carcinoma. Prog Med Virol 39:167–203

    Google Scholar 

  312. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B (1994) Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 57:1–9

    CAS  PubMed  Google Scholar 

  313. Spandidos DA, Anderson MLM (1989) Oncogenes and oncosuppressor genes: Their involvement in cancer. J Pathol 157:1–10

    Google Scholar 

  314. Squire RA, Levitt MH (1975) Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res 35:3214–3223

    Google Scholar 

  315. Steinberg P, Steinbrecher R, Radaeva S, Schirmacher P, Dienes HP, Oesch F, Bannasch P (1994) Oval cell lines OC/cDE6 and OC/cDE22 give rise to cholangio-cellular and undifferentiated carcinomas after transformation. Lab Invest 71:700–709

    Google Scholar 

  316. Stewart BW (1994) Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 86:1286–1296

    Google Scholar 

  317. Stewart HL, Willilams G, Keysser CH, Lombard LS, Montali RJ (1980) Histologic typing of liver tumors of the rat. J Natl Cancer Inst 61:179–206

    Google Scholar 

  318. Stoloff L (1989) Aflatoxin is not a probable human carcinogen: the published evidence is sufficient. Regul Toxicol Pharmacol 10:272–283

    Google Scholar 

  319. Strauss BS (1992) The origin of point mutations in human tumor cells. Cancer Res 52:249–253

    Google Scholar 

  320. Stuver SO, Trichopoulos D (1994) Liver Cancer. In: Trends in cancer incidence and mortality. Cancer Surv 19/20:99–124

    Google Scholar 

  321. Sugimura T (1992) Multistep carcinogenesis: A 1992 perspective. Science 258:603–607

    Google Scholar 

  322. Tanooka H (1988) Monoclonal growth of cancer cells: Experimental evidence. Jpn J Cancer Res 79:657–665

    Google Scholar 

  323. Tao L-C (1991) Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cancer 68:341–347

    Google Scholar 

  324. Tarsetti F, Lenzi R, Salvi R, Schuler E, Rijhsinghani K, Lenzen R, Tavoloni N (1993) Liver carcinogenesis associated with feeding of ethionine in a choline-free diet: Evidence against a role of oval cells in the emergence of hepatocellular carcinoma. Hepatology 18:596–603

    Google Scholar 

  325. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S (1994) p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 54:231–235

    Google Scholar 

  326. Thamavit W, Ngamying M, Boonpucknavig V, Boonpucknavig S, Moore MA (1987) Enhancement of DEN-induced hepatocellular nodule development by Opisthorchis viverrini infection in Syrian golden hamsters. Carcinogenesis 8:1351–1353

    Google Scholar 

  327. Thamavit W, Moore MA, Hiasa Y, Ito N (1988) Generation of high yields of Syrian hamster cholangiocellular carcinomas and hepatocellular nodules by combined nitrite and aminoyrine administration and Opisthorchis viverrini infection. Jpn J Cancer Res 79:909–916

    Google Scholar 

  328. Theise ND, Schwartz M, Miller C, Thung SN (1992) Macro-regenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis. Hepatology 16:949–955

    Google Scholar 

  329. Theise ND, Lapook JD, Thung SN (1993) A macroregenerative nodule containing multiple foci of hepatocellular carcinoma in a noncirrhotic liver. Hepatology 17:993–996

    Google Scholar 

  330. Thomas C (1961) Zur Morphologie der durch Diäthylnitrosamin erzeugten Leberveränderungen und Tumoren bei der Ratte. Z Krebsforschg 64:224–233

    Google Scholar 

  331. Thorgeirsson SS (1993) Hepatic stem cells. Am J Pathol 142:1331–1333

    Google Scholar 

  332. Thorgeirsson SS, Evarts RP (1992) Growth and differentiation of stem cells in adult rat liver. In: Sirica AE (ed) The role of cell types in hepatocarcinogenesis. CRC Press, Boca Raton, pp 109–120

    Google Scholar 

  333. Toshkov I, Chisari FV, Bannasch P (1994) Hepatic preneoplasia in hepatitis B virus transgenic mice. Hepatology 20:1162–1172

    Google Scholar 

  334. Travis CC (1993) The search for liver stem cells picks up. Science 259:1829

    Google Scholar 

  335. Travis CC, Belefant H (1992) Promotion as a factor in carcinogenesis. Toxicol Lett 60:1–9

    Google Scholar 

  336. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797–1801

    Google Scholar 

  337. Ueda N, Shah SV (1994) Apoptosis. J Lab Clin Med 124:169–177

    Google Scholar 

  338. Unsal H, Yakicier C, Marçais C, Kew M, Volkmann M, Zentgraf H, Isselbacher KJ, Ozturk M (1994) Genetic heterogeneity of hepatocellular carcinoma. Proc Natl Acad Sci USA 91:822–826

    Google Scholar 

  339. Uriel J (1979) Retrodifferentiation and the fetal patterns of gene expression in cancers. Adv Cancer Res 29:127–174

    Google Scholar 

  340. Vesselinovitch SD, Mihailovich N (1984) Kinetics of induction and growth of basophilic foci and development of hepatocellular carcinoma by diethylnitrosamine in the infant mouse. In: Popp JA (ed) Mouse liver neoplasia. Current perspectives. Hemisphere Publishing, Washington, pp 61–83

    Google Scholar 

  341. Volkmann M, Hofmann WJ, Müller M, Räth U, Otto G, Zentgraf H, Galle PR (1994) p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene 9:195–204

    Google Scholar 

  342. Wands JR, Blum HE (1991) Primary hepatocellular carcinoma. N Engl J Med 325:729–731

    Google Scholar 

  343. Wang J, Chenivesse X, Henglein B, Bréchot C (1990) Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343:555–557

    Google Scholar 

  344. Wanless IR (1990) Micronodular transformation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11:787–797

    Google Scholar 

  345. Warwick GP, Roberts JJ (1967) Persistent binding of butter yellow metabolites to rat liver DNA. Nature 213:1206–1207

    Google Scholar 

  346. Webber EM, Wu JC, Wang L, Merlino G, Fausto N (1994) Overexpression of transforming growth factor-α causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 145:398–408

    Google Scholar 

  347. Weber E, Bannasch P (1994) Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine. Carcinogenesis 15:1219–1226

    Google Scholar 

  348. Weber E, Bannasch P (1994) Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in step experiments by oral exposure to N-nitrosomorpholine. Carcinogenesis 15:1227–1234

    Google Scholar 

  349. Weber E, Bannasch P (1994) Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine. Carcinogenesis 15:1235–1242

    Google Scholar 

  350. Weinberg AG, Finegold MJ (1986) Primary hepatic tumors in childhood. In: Bennington JL (ed) Pathology of neoplasia in children and adolescents. (Major problems in pathology, vol 18.) Saunders, Philadelphia, pp 333–371

    Google Scholar 

  351. Weinberg RA (1989) Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 49:3713–3721

    Google Scholar 

  352. Weinberg WC, Ng YK, Iannaccone PM (1992) Clonal analysis of hepatic neoplasms by mosaic pattern. In: Sirica AE (ed) The role of cell types in hepatocarcinogenesis. CRC Press, Boca Raton, pp 30–53

    Google Scholar 

  353. Weinhouse S (1982) Changing perceptions of carbohydrate metabolism in tumors. In: Arnott MS, Eys J van, Wang Y-M (eds) Molecular interrelations of nutrition and cancer. Raven Press, New York, pp 167–181

    Google Scholar 

  354. Weinstein IB (1988) The origins of human cancer: Molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment. Cancer Res 48:4135–4143

    Google Scholar 

  355. Wigley C (1986) Chemical carcinogens and precancer. In: Franks LM, Teich NM (eds) Introduction to the cellular and molecular biology of cancer. Oxford University Press, Oxford, pp 131–153

    Google Scholar 

  356. Wild CP, Jansen LAM, Cova L, Montesano R (1993) Molecular dosimetry of aflatoxin exposure: Contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus. Environ Health Perspect 99:115–122

    Google Scholar 

  357. Williams GM (1976) Functional markers and growth behavior of preneoplastic hepatocytes. Cancer Res 36:2540–2543

    Google Scholar 

  358. Willis RA (1967) Pathology of tumours, 4th edn. Butterworths, London

    Google Scholar 

  359. Witz G (1991) Active oxygen species as factors in multistage carcinogenesis. Proc Soc Exp Biol Med 198:675–682

    Google Scholar 

  360. Wogan GN (1992) Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res [Suppl] 52:2114s-2118s

    Google Scholar 

  361. Wogan GN, McMahon G (1989) Experimental induction of hepatocellular carcinoma by chemical carcinogens. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Falk Symposium 51. Kluwer Academic Publishers, Dordrecht, pp 187–195

    Google Scholar 

  362. Wyllie AH (1994) Death from inside out: an overview. Philos Trans R Soc London [Biol] 345:237–241

    Google Scholar 

  363. Yeh FS, Yu MC, Mo C-C, Luo S, Tong MJ, Henderson BE (1989) Hepatitis B virus, aflatoxins and hepatocellular carcinoma in Southern Guanxi, China. Cancer Res 49:2506–2509

    Google Scholar 

  364. Yuspa SH, Poirier MC (1988) Chemical carcinogenesis: From animal models to molecular models in one decade. Adv Cancer Res 50:25–69

    Google Scholar 

  365. Zerban H, Radig S, Kopp-Schneider A, Bannasch P (1994) Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Carcinogenesis 15:2467–2473

    Google Scholar 

  366. Zhang Y-J, Chen C-J, Lee C-S, Haghighi B, Yang G-Y, Wang LW, Feitelson M, Santella R (1991) Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue. Carcinogenesis 12:2247–2252

    Google Scholar 

  367. Zhao M, Zhang NX, Du ZY, Laissue JA, Zimmermann A (1994) Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labelling, and their features resemble distinct grades of hepatocellular carcinoma. Histol Histopathol 9:73–83

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology, University of New Brunswick, Fredericton, New Brunswick, Canada

    K. Aterman

Authors
  1. K. Aterman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aterman, K. Hepatic neoplasia: reflections and ruminations. Vichows Archiv A Pathol Anat 427, 1–18 (1995). https://doi.org/10.1007/BF00203732

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00203732

Keywords

Search

Navigation